Insider Selling: LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells 18,845 Shares of Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Lisa K. Miller sold 18,845 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. The trade was a 5.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

LifeStance Health Group Stock Down 2.2 %

LFST stock traded down $0.15 during mid-day trading on Tuesday, reaching $6.74. The company had a trading volume of 2,300,220 shares, compared to its average volume of 1,492,653. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The company has a market capitalization of $2.59 billion, a price-to-earnings ratio of -25.92 and a beta of 1.27. The firm has a fifty day simple moving average of $7.77 and a 200 day simple moving average of $7.35. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61.

Institutional Investors Weigh In On LifeStance Health Group

A number of hedge funds have recently bought and sold shares of LFST. Blue Trust Inc. raised its position in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares in the last quarter. Townsquare Capital LLC acquired a new stake in shares of LifeStance Health Group during the 3rd quarter worth about $73,000. R Squared Ltd acquired a new stake in shares of LifeStance Health Group during the 4th quarter worth about $80,000. Ameriprise Financial Inc. acquired a new stake in shares of LifeStance Health Group during the 4th quarter worth about $87,000. Finally, Cibc World Markets Corp acquired a new stake in shares of LifeStance Health Group during the 4th quarter worth about $96,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on LFST shares. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research note on Monday, December 16th. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $8.63.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.